Final patient visit marks major milestone in FDA IDE study, advancing treatment options for patients not eligible for knee replacement....
New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...
Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories....
Court Blocks Unauthorized Distribution of InMode’s RF Microneedling Devices and Cartridges in Major IP Protection Win ...
Company adopts ClearNote Health's early detection tool to identify pancreatic cancer at stage I, aiming to improve outcomes for high-risk individuals....
Marie® may soon become the first FDA-cleared upright particle therapy solution, aiming to reshape radiotherapy delivery across the U.S....
The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....
Marking its first investment in Asia and the cardiovascular gene therapy space, Angelini Ventures backs Singapore-based Nuevocor to drive clinical development of NVC-001 for LMNA DCM....
Magnetom Flow RT Pro Edition enables adaptive radiotherapy with AI-powered imaging, helium-independent cooling, and simplified installation near linear accelerators for enhanced patient care....
New QA system aims to enhance geometric accuracy in MR-guided radiation therapy and stereotactic planning ...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
